IBRX - CIK 0001326110
As of 2026-06-10, ImmunityBio, Inc. (IBRX) has a market capitalization of $7.31 B, making it the #1120 most valuable US-listed company.
| Date | Market cap |
|---|---|
| 2026-06-10 | $7.31 B |
| 2026-05-29 | $7.93 B |
| 2026-05-28 | $8.26 B |
| 2026-05-26 | $8.33 B |
| 2026-05-25 | $7.56 B |
| 2026-05-24 | $7.56 B |
| 2026-05-22 | $7.56 B |
Readings accumulate daily as market data refreshes, combining SEC-reported share counts with live prices.
As of 2026-06-10, ImmunityBio, Inc. (IBRX) has a market capitalization of $7.31 B, making it the #1120 most valuable US-listed company.
ImmunityBio, Inc. is the #1120 largest US-listed company by market capitalization.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.